AXP107-11 in Combination With Standard Gemcitabine (Gemzar® ) Therapy for Treatment in Patients With Pancreatic Cancer
Clinical trial NCT01182246 · UNKNOWN
Trial details
- NCT number
- NCT01182246
- Sponsor
- Axcentua Pharmaceuticals AB
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-01
- Primary completion
- 2016-03-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.